Third quarter earnings briefs: Lilly, Bristol, Shire, Biomarin, Alexion (Pink Sheet - Informa) - Oct 28, 2013 - "A read-out from a second Phase III study is expected at the end of 2014, and launch might be possible in 2016"
Anticipated launch • Anticipated P3 data • Diabetes
|
|
A subscription to The Pink Sheet is required to access this article
|